Author: OurCrowd

[Insightec in Yahoo Finance] Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results of the First-in-Human Phase 0/1 Clinical Trial of Non-Invasive Sonodynamic Therapy for Recurrent Glioblastoma

PHOENIX, Ariz., Sept. 20, 2021 (GLOBE NEWSWIRE) — The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, and SonALAsense, a pioneer in developing non-invasive sonodynamic therapy (SDT) for managing fatal cancers so patients can become survivors, today announced positive initial results of the first-in-human Phase 0/1 clinical trial of SDT in recurrent glioblastoma patients. The initial results indicate SDT rapidly leads to targeted oxidative stress and cell death in human glioblastoma tissue. SDT was well-tolerated in all patients. Read more...

Read More

[ByondXR in Bezinga] How Businesses Are Getting a Makeover With ByondXR

We live in a very image-focused world and this is particularly true of the business world. Businesses pay top dollar to advertise on billboards, posters, online, and in any other way so that they can be seen in a favorable light. They also go through great pains to make sure that customers can get an accurate view of their products, with high-definition video and pictures. Read more...

Read More